Related Experiment Videos
CYP450 network shifts in MASLD/MASH: from pathogenesis to nutrition-informed modulation
Sümeyye Koç1, Sude Toydemir2, Gökay Vardar3
1Department of Nutrition Dietetics, Faculty of Health Sciences, Lokman Hekim University, Ankara, Türkiye; Department of Molecular Biology and Genetics, Faculty of Science, Boğaziçi University, Istanbul, Türkiye.
Dietary factors significantly impact liver health in metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). Understanding how nutrition affects drug-metabolizing enzymes (CYP450) is crucial for managing these conditions.
Area of Science:
- Hepatology and Nutritional Science
- Drug Metabolism and Xenobiotic Interactions
- Molecular and Cellular Biology
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are rising health concerns linked to obesity and poor diet.
- Cytochrome P450 (CYP450) enzymes are critical for drug metabolism, lipid handling, and responding to nutritional and environmental exposures, but their role in MASLD/MASH is not fully understood from a nutritional perspective.
Purpose of the Study:
- To review and integrate the current understanding of how diet-related exposures influence hepatic CYP450 pathways in the context of MASLD/MASH.
- To map the relationships between dietary patterns, food contaminants, and bioactive compounds with CYP450 function in the metabolically compromised liver.
Main Methods:
- A qualitative framework was used to review existing literature on nutrition-exposure-CYP relationships in MASLD/MASH.
- Evidence from human tissue studies, animal models, in vitro experiments, and mechanistic studies was integrated.
Main Results:
- Obesity, high-fat diets, fructose, and specific fatty acid compositions can alter hepatic CYP450 activity and expression, particularly CYP3A4, in MASLD/NASH.
- Metabolic inflammation appears to promote pro-oxidant CYP pathways (e.g., CYP2E1) while potentially impairing detoxification pathways (e.g., CYP3A).
- Food contaminants like nitrosamines and aflatoxin B1 may undergo CYP-dependent bioactivation, though human validation in MASLD/MASH is limited.
Conclusions:
- Nutrition-related remodeling of CYP450 enzymes is a key interface linking diet, oxidative stress, xenobiotic handling, and MASLD/MASH progression.
- Future research should combine dietary assessments with CYP activity measures, oxidative stress biomarkers, and gut-liver axis markers for a comprehensive understanding.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Phase I Oxidative Reactions: Overview
Bioactivation and Tissue Toxicity
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Drug Metabolism: Phase I Reactions
Redox Reactions